Research Project

Project Title:

ILLUMINATE-C

Project Type:

Clinical Trial, Enrolment terminated

Disease group(s):

Metabolic & stone disorders

Project Summary:

A Single Arm Study to Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Lumasiran in Patients with Advanced Primary Hyperoxaluria Type 1 (PH1).

Lead principal investigator(s):

Francesco Emma, Rome

Co-investigator(s):

Isabella Guzzo, Rome

Project Period:

08/2020   -   12/2060

EudraCT Nr.:

2019-001346-17

« Back to research page